ID   BGC-823/DOX
AC   CVCL_E8Z4
RX   PubMed=10374555;
CC   Problematic cell line: Contaminated. Parent cell line (BGC-823) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3360 ! BGC-823
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=10374555;
RA   Zheng, Guo-Qiang
RA   Liu, Xu-Yi
RA   Han, Fu-Sheng
RA   Xu, Guang-Wei
RT   "Establishment and characterization of doxorubicin-resistant
RT   BGC-823/DOX of human gastric cancer cell line.";
RL   Zhonghua Wai Ke Za Zhi 35:262-264(1997).
//